Soleno Therapeutics Inc banner

Soleno Therapeutics Inc
F:6XC

Watchlist Manager
Soleno Therapeutics Inc Logo
Soleno Therapeutics Inc
F:6XC
Watchlist
Price: 44.86 EUR Market Closed
Market Cap: €1.7B

Wall St Price Targets

6XC Price Targets Summary
Soleno Therapeutics Inc

There are no price targets for 6XC.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Soleno Therapeutics Inc Competitors:
Price Targets
ORLY
O'Reilly Automotive Inc
23% Upside

Revenue
Forecast

41% / Year
Past Growth
75% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
41% / Year
Past Growth
75% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.

Gross Profit
Forecast

N/A
Past Growth
71% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
71% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 3 years is 71%.

Operating Income
Forecast

N/A
Past Growth
307% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
307% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is 307%.

Pre-Tax Income
Forecast

N/A
Past Growth
216% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
N/A
Past Growth
216% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 216%.

Net Income
Forecast

N/A
Past Growth
197% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
197% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Net Income over the next 3 years is 197%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 6XC's stock price target?
Not Available

6XC does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Soleno Therapeutics Inc?
Projected CAGR
75%

Over the last 12 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 3 years is 75%.

What is the Gross Profit forecast for Soleno Therapeutics Inc?
Projected CAGR
71%

The compound annual growth rate for Gross Profit over the next 3 years is 71%.

What is the Operating Income forecast for Soleno Therapeutics Inc?
Projected CAGR
307%

The compound annual growth rate for Operating Income over the next 3 years is 307%.

What is the Pre-Tax Income forecast for Soleno Therapeutics Inc?
Projected CAGR
216%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 216%.

What is the Net Income forecast for Soleno Therapeutics Inc?
Projected CAGR
197%

The compound annual growth rate for Net Income over the next 3 years is 197%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett